Jane Street’s Evogene EVGN Stock Holding History

Jane Street’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,530	Closed	-$52K	–	10125
2021 Q2	$52K	Sell	1,530 -1,720	-53%	-$67.4K	﹤0.01%	9495
2021 Q1	$164K	Buy	+3,250	New	+$201K	﹤0.01%	8405

Other funds holding EVGN

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

DSC

Daytona Street Capital Saint Louis, Missouri $141M AUM 14.38% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Jane Street's EVGN Position: Q2 2026 in Review

Jane Street sold out of Evogene (EVGN) in Q2 2026, closing a stake of 18,500 shares — an estimated $14.2K sold.

Jane Street first reported a position in EVGN in Q1 2014 and held it in 28 quarters. The position peaked at $825K in Q4 2020. 13 funds tracked by Wall St. Rank hold EVGN as of Q2 2026.

Jane Street reported no remaining Evogene position as of Q2 2026 after selling out during the quarter.
Jane Street sold 18,500 Evogene shares in Q2 2026, an estimated $14.2K.
Jane Street first reported a position in Evogene in Q1 2014 and held it in 28 quarters.
Jane Street's Evogene position peaked at $825K in Q4 2020.
13 funds tracked by Wall St. Rank held Evogene as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.